Federal Circuit Orders Extra Mayo
Last Wednesday we commented on a Delaware decision (Andrews, J.) applying the Federal Circuit’s Mayo analysis to find that a patent on a new dosing regimen for an old drug lacked patentable subject matter under 35 U.S.C. § 101. Alice in Pharma Land. Two days later, the Federal Circuit affirmed another Delaware decision (Stark, J.)…